Jamkas Pharmaceuticals Launches Cost-Effective Third-Party Manufacturing Model for Emerging Pharma Brand

VMPL, Small-scale pharma, Market demand, Strategic expansion, Iso certified, Diverse product range, Advertorial Disclaimer
Business
image